Navigation Links
New Class of Instruments for Flexible Surgery from Apollo Endosurgery® Used in Cancer Therapy
Date:4/19/2011

AUSTIN, Texas, April 19, 2011 /PRNewswire/ -- Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the patient spent one night in the hospital and was prescribed Acetaminophen for pain. This is a stark contrast to minimally invasive or open surgeries which necessitate incisions and can require anywhere  from two to eight weeks of recovery time.

"Revolutionary cases like this one begin to reveal the potential of new flexible surgery techniques and tools designed to remove early stage lesions from the colon, esophagus, and stomach," says Jay Redan, MD, Medical Director of Minimally Invasive Surgery at Florida Hospital Celebration Health.

Development of flexible surgical instruments like the one used at Florida Hospital could not have been possible without the support and generous funding from the Cancer Prevention Research Institute of Texas (CPRIT). Dennis McWilliams, CEO and President for Apollo Endosurgery®, says, "Apollo Endosurgery is honored to be among the first of three companies in Texas to have received a commercialization grant from CPRIT. We've used these funds to advance therapeutic flexible endoscopy and other less invasive therapies. We're excited to see the application of our tools in the endoluminal removal of lesions from the stomach."

CPRIT is a state agency dedicated to expediting innovation and commercialization in the area of cancer research and to enhancing access to evidence-based prevention programs and services throughout Texas.  Learn more about the work of CPRIT at http://www.cprit.state.tx.us/.

To learn more about flexible surgery instruments, including the OverStitch® Endoscopic Suturing System and the SuMO™ Tissue Access and Resection System develop by Apollo Endosurgery®, visit www.apolloendo.com.

About Apollo Endosurgery®, Inc.

Apollo Endosurgery®, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastroenterology.  Flexible surgery minimizes the trauma of surgical access by taking advantage of natural orifices to deliver surgical tools to targeted areas.  All of Apollo's products are compatible with existing flexible endoscope platforms.  Apollo Endosurgery® was cofounded with the Apollo Group, a unique collaboration of physicians from the Mayo Clinic, Johns Hopkins University, Medical University of South Carolina, the University of Texas Medical Branch and the Chinese University of Hong Kong.  The company is funded by PTV Sciences, H.I.G. Ventures and has received a grant from the Cancer Prevention Research Institute of Texas. 

For more information:
Ted Stephens
Director of Marketing
Apollo Endosurgery®, Inc.
512-328-9990 (o)
513-312-9161 (m)
www.apolloendo.com

Follow us on Twitter - twitter.com/Apollo_Endo


'/>"/>
SOURCE Apollo Endosurgery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medicare Part B Subscribers Who Made a Percentage Co-Payment for Certain Drugs May Be Able To Get a Refund from a Class Action Settlement
2. MonoSol Rx Issued Strategic US Patent Governing the Production of Pharmaceutical Films Containing Specific Drugs and Drug Classes
3. ABSTRAL® (fentanyl) Sublingual Tablets CII, First-in-class, Sublingual, Immediate Release Opioid for Managing Breakthrough Cancer Pain, Now Available in the U.S.
4. Bayer Gets $100M Gender Class Action Headache
5. Life Technologies Initiates Clinical Trials Leading to 510(k) Submission of a Class I and Class II HLA Sequence-Based Typing Solution
6. iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
7. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
8. Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone
9. Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits
10. K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock
11. Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Jan. 20, 2017 ResMed (NYSE: RMD ), ... Winter Haven, Florida ) today announced they have agreed ... and 3B will be permitted to sell their existing products in ... one-time settlement payment to 3B to close the Florida ... include an admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... Jan. 20, 2017  Faruqi & Faruqi, LLP, a leading ... or the "Company") (NASDAQ: KMPH ) of the ... certain officers and directors and underwriters of the Company,s April ... role of lead plaintiff. The lawsuit has been ... for Johnson County on behalf of ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... to their offering. ... This research service on the global pharmaceutical stability testing market ... of the key participants in the market. The ... 2020. The market is expected to grow at a CAGR of ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... January 23, 2017 , ... DMG Productions is proud to ... Jr., scheduled to broadcast Saturday, January 28, 2017 at 5:00pmEST. , This segment ... to address the limitations of fatigue monitoring technologies within the mining industry. Today ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... taught by healthcare management and evaluation leaders with decades of experience who remain ... in the United States healthcare system, there is a renewed demand for versatile, ...
(Date:1/23/2017)... Indiana (PRWEB) , ... January 23, 2017 , ... ... Center for Assisted Living (IHCA/INCAL), will serve as a healthcare industry expert at ... 23. The panel discussion, moderated by Inside Indiana Business host Gerry Dick, will ...
(Date:1/23/2017)... ... 23, 2017 , ... Steviva Ingredients, makers of all-natural sweeteners ... National Organic Program (NOP) for its Portland SQF Level 2 manufacturing facility. ... handling systems to complement our current rigorous food-safety management systems,” said Yishu Hou, ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... partnership with the American Society of Anesthesiologists® (ASA®), the Foundation for Anesthesia ... Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, encourages proposals supporting ...
Breaking Medicine News(10 mins):